1. Home
  2. DMAC vs IONR Comparison

DMAC vs IONR Comparison

Compare DMAC & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • IONR
  • Stock Information
  • Founded
  • DMAC 2000
  • IONR 2001
  • Country
  • DMAC United States
  • IONR Australia
  • Employees
  • DMAC N/A
  • IONR N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • IONR
  • Sector
  • DMAC Health Care
  • IONR
  • Exchange
  • DMAC Nasdaq
  • IONR Nasdaq
  • Market Cap
  • DMAC 274.1M
  • IONR 319.2M
  • IPO Year
  • DMAC N/A
  • IONR N/A
  • Fundamental
  • Price
  • DMAC $4.82
  • IONR $3.85
  • Analyst Decision
  • DMAC Strong Buy
  • IONR
  • Analyst Count
  • DMAC 3
  • IONR 0
  • Target Price
  • DMAC $7.00
  • IONR N/A
  • AVG Volume (30 Days)
  • DMAC 118.6K
  • IONR 20.8K
  • Earning Date
  • DMAC 11-13-2024
  • IONR 01-01-0001
  • Dividend Yield
  • DMAC N/A
  • IONR N/A
  • EPS Growth
  • DMAC N/A
  • IONR N/A
  • EPS
  • DMAC N/A
  • IONR N/A
  • Revenue
  • DMAC N/A
  • IONR N/A
  • Revenue This Year
  • DMAC N/A
  • IONR N/A
  • Revenue Next Year
  • DMAC N/A
  • IONR N/A
  • P/E Ratio
  • DMAC N/A
  • IONR N/A
  • Revenue Growth
  • DMAC N/A
  • IONR N/A
  • 52 Week Low
  • DMAC $2.14
  • IONR $2.90
  • 52 Week High
  • DMAC $6.41
  • IONR $9.35
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 47.28
  • IONR 26.53
  • Support Level
  • DMAC $5.05
  • IONR $4.41
  • Resistance Level
  • DMAC $5.74
  • IONR $5.00
  • Average True Range (ATR)
  • DMAC 0.37
  • IONR 0.27
  • MACD
  • DMAC -0.08
  • IONR -0.07
  • Stochastic Oscillator
  • DMAC 28.10
  • IONR 9.16

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About IONR ioneer Ltd

Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.

Share on Social Networks: